Structural Imaging and Parkinson’s Disease: Moving Toward Quantitative Markers of Disease Progression
Parkinson’s disease (PD) is a progressive age-related neurodegenerative disorder. Although the pathological hallmark of PD is dopaminergic cell death in the substantia nigra pars compacta, widespread neurodegenerative changes occur throughout the brain as disease progresses. Postmortem studies, for...
Main Authors: | Sterling, N.W., Lewis, M.M., Du, G., Huang, X. |
---|---|
Format: | Online |
Language: | English |
Published: |
IOS Press
2016
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5008231/ |
Similar Items
-
Impairment of Vowel Articulation as a Possible Marker of Disease Progression in Parkinson's Disease
by: Skodda, Sabine, et al.
Published: (2012) -
Recent Progress of Imaging Agents for Parkinson's Disease
by: Wu, Xiaoai, et al.
Published: (2014) -
Targeting the Progression of Parkinson’s Disease
by: George, J.L, et al.
Published: (2009) -
Multimodal Imaging Signatures of Parkinson's Disease
by: Bowman, F. DuBois, et al.
Published: (2016) -
Accuracy of MR markers for differentiating Progressive Supranuclear Palsy from Parkinson's disease
by: Zanigni, Stefano, et al.
Published: (2016)